INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 1 filers reported holding INHIBRX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,423,676 | -23.7% | 459,056 | +7.9% | 0.02% | -19.0% |
| Q2 2023 | $11,047,043 | +83.8% | 425,541 | +33.6% | 0.02% | +75.0% |
| Q1 2023 | $6,010,188 | -23.7% | 318,505 | -0.3% | 0.01% | -25.0% |
| Q4 2022 | $7,873,587 | +28.8% | 319,545 | -6.2% | 0.02% | +23.1% |
| Q3 2022 | $6,112,000 | +112.0% | 340,604 | +34.0% | 0.01% | +116.7% |
| Q2 2022 | $2,883,000 | -21.4% | 254,112 | +54.2% | 0.01% | 0.0% |
| Q1 2022 | $3,670,000 | -67.5% | 164,775 | -36.3% | 0.01% | -66.7% |
| Q4 2021 | $11,291,000 | +44.9% | 258,581 | +10.5% | 0.02% | +38.5% |
| Q3 2021 | $7,791,000 | +145.3% | 233,917 | +102.6% | 0.01% | +160.0% |
| Q2 2021 | $3,176,000 | – | 115,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,023,325 | $11,615,000 | 3.23% |
| Opaleye Management Inc. | 590,000 | $6,697,000 | 3.02% |
| Sio Capital Management, LLC | 365,210 | $4,145,000 | 1.56% |
| Perceptive Advisors | 1,914,592 | $21,731,000 | 0.68% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 794,682 | $9,020,000 | 0.65% |
| Birchview Capital, LP | 70,448 | $800,000 | 0.58% |
| Meridian Wealth Advisors, LLC | 122,315 | $1,388,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $60,222,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 1,412,236 | $16,029,000 | 0.18% |
| Alaethes Wealth LLC | 19,341 | $220,000 | 0.16% |